TY  - GEN
AU  - Lip,Gregory Y H
AU  - Rasmussen,Lars H
AU  - Olsson,S Bertil
AU  - Jensen,Eva C
AU  - Persson,Anders L
AU  - Eriksson,Ulf
AU  - Wåhlander,Karin F C
TI  - Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists
SN  - 1522-9645
PY  - 2010///0330
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Anticoagulants
KW  - therapeutic use
KW  - Antifibrinolytic Agents
KW  - Atrial Fibrillation
KW  - complications
KW  - Biomarkers
KW  - metabolism
KW  - Bleeding Time
KW  - Embolism
KW  - prevention & control
KW  - Female
KW  - Fibrin Fibrinogen Degradation Products
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Stroke
KW  - Thrombin
KW  - antagonists & inhibitors
KW  - Vitamin K
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/eurheartj/ehp318
ER  -